JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xi, Z.-X.
Right arrow Articles by Stein, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xi, Z.-X.
Right arrow Articles by Stein, E. A.

Vol. 290, Issue 3, 1369-1374, September 1999

Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release1

Zheng-Xiong Xi and Elliot A. Stein

Departments of Cellular Biology, Neurobiology, and Anatomy (Z.-X.X., E.A.S.), Psychiatry and Behavioral Medicine (E.A.S.), Pharmacology (E.A.S.), and The Biophysics Research Institute (E.A.S.), Medical College of Wisconsin, Milwaukee, Wisconsin

An emerging hypothesis to explain the mechanism of heroin-induced positive reinforcement states that opiates inhibit gamma -aminobutyric acid (GABA)-ergic interneurons within the mesocorticolimbic dopamine (DA) system to disinhibit DA neurons. In support of this hypothesis, we report that the development of heroin self-administration (SA) behavior in drug-naive rats and the maintenance of SA behavior in heroin-trained rats were both suppressed when the GABAB receptor agonist baclofen was coadministered with heroin. Microinjections of baclofen into the ventral tegmental area (VTA), but not the nucleus accumbens, decreased heroin reinforcement as indicated by a compensatory increase in SA behavior. Additionally, baclofen administered alone or along with heroin dose-dependently reduced heroin-induced DA release. This effect was blocked partially by intra-VTA infusion of the GABAB antagonist 2-hydroxysaclofen, suggesting an additional, perhaps GABAA receptor-mediated, disinhibitory effect. Taken together, these experiments, for the first time, demonstrate that heroin-reinforced SA behavior and nucleus accumbens DA release are mediated predominantly by GABAB receptors in the VTA and suggest that baclofen may be an effective agent in the treatment of opiate abuse.


0022-3565/99/2903-1369$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
C. H. Yang, B. H. Lee, and S. H. Sohn
A Possible Mechanism Underlying the Effectiveness of Acupuncture in the Treatment of Drug Addiction
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 257 - 266.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
O. AMEISEN
COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN
Alcohol Alcohol., March 1, 2005; 40(2): 147 - 150.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Bettler, K. Kaupmann, J. Mosbacher, and M. Gassmann
Molecular Structure and Physiological Functions of GABAB Receptors
Physiol Rev, July 1, 2004; 84(3): 835 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Leite-Morris, E. Y. Fukudome, M. H. Shoeb, and G. B. Kaplan
GABAB Receptor Activation in the Ventral Tegmental Area Inhibits the Acquisition and Expression of Opiate-Induced Motor Sensitization
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 667 - 678.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
K. Brebner, A. R. Childress, and D. C. S. Roberts
A POTENTIAL ROLE FOR GABAB AGONISTS IN THE TREATMENT OF PSYCHOSTIMULANT ADDICTION
Alcohol Alcohol., September 1, 2002; 37(5): 478 - 484.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
Z.-X. Xi and E. A. Stein
GABAergic MECHANISMS OF OPIATE REINFORCEMENT
Alcohol Alcohol., September 1, 2002; 37(5): 485 - 494.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
L. Fattore, G. Cossu, M. C. Martellotta, and W. Fratta
BACLOFEN ANTAGONIZES INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN MICE AND RATS
Alcohol Alcohol., September 1, 2002; 37(5): 495 - 498.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. G. Bowery, B. Bettler, W. Froestl, J. P. Gallagher, F. Marshall, M. Raiteri, T. I. Bonner, and S. J. Enna
International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function
Pharmacol. Rev., June 1, 2002; 54(2): 247 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. J. De Vries and T. S. Shippenberg
Neural Systems Underlying Opiate Addiction
J. Neurosci., May 1, 2002; 22(9): 3321 - 3325.
[Full Text] [PDF]


Home page
Mol. Interv.Home page
S. J. Enna
A GABAB Mystery: The Search for Pharmacologically Distinct GABAB Receptors
Mol. Interv., October 1, 2001; 1(4): 208 - 218.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. L. Jackson, S. G. Wood, and D. E. Kuehl
A {gamma}-Aminobutyric AcidB Agonist Reverses the Negative Feedback Effect of Testosterone on Gonadotropin-Releasing Hormone and Luteinizing Hormone Secretion in the Male Sheep
Endocrinology, November 1, 2000; 141(11): 3940 - 3945.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-X. Xi and E. A. Stein
Increased Mesolimbic GABA Concentration Blocks Heroin Self-Administration in the Rat
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 613 - 619.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.